SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
72.00
+0.10 (0.14%)
Jul 30, 2026, 9:54 AM CST
SYN-TECH Chem. & Pharm. Market Cap
SYN-TECH Chem. & Pharm. has a market cap or net worth of 3.21 billion as of July 29, 2026. Its market cap has decreased by -7.82% in one year.
Market Cap
3.21B
Enterprise Value
2.31B
Revenue
1.26B
Ranking
n/a
PE Ratio
12.50
Stock Price
72.00
ChartMarket Cap Chart
Since October 26, 2004, SYN-TECH Chem. & Pharm.'s market cap has increased from 412.78M to 3.21B, an increase of 676.72%. That is a compound annual growth rate of 9.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 3.21B | -2.57% |
| Dec 31, 2025 | 3.29B | -21.66% |
| Dec 31, 2024 | 4.20B | 10.56% |
| Dec 29, 2023 | 3.80B | 1.19% |
| Dec 30, 2022 | 3.75B | 43.53% |
| Dec 30, 2021 | 2.62B | 12.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovate Biotechnology | 3.65B |
| OBI Pharma | 3.57B |
| Senhwa Biosciences | 3.52B |
| Sagittarius Life Science | 3.36B |
| Apex Biotechnology | 3.17B |
| Shine-On BioMedical | 3.14B |
| 3D Global Biotech | 3.09B |
| Great Novel Therapeutics Biotech & Medicals | 3.07B |